Total human chorionic gonadotropin IVD, kit, rapid ICT, clinical

Total human chorionic gonadotropin (HCG) IVD kits use rapid immunochromatographic tests (ICT) to detect pregnancy or assess pregnancy risks like miscarriage or Down syndrome. These tests analyze clinical specimens—such as urine or blood—to provide results quickly, often within minutes, in lab or point-of-care settings. They identify multiple HCG forms, including intact and fragmented subunits, for broader diagnostic accuracy than traditional methods.

These devices are typically regulated as in vitro diagnostics (IVDs) and may require compliance with standards for accuracy, reliability, and clinical performance. They are supplied as kits containing reagents and instructions for use, often classified based on risk level and intended clinical application. Availability and regulatory pathways vary by jurisdiction, ensuring proper oversight for diagnostic safety and efficacy.